Gayam Vijay, Khalid Mazin, Shrestha Binav, Hossain Muhammad Rajib, Dahal Sumit, Garlapati Pavani, Gill Arshpal, Mandal Amrendra Kumar, Sangha Ruby
Interfaith Medical Center, Brooklyn, NY, USA.
J Investig Med High Impact Case Rep. 2018 Mar 14;6:2324709618761754. doi: 10.1177/2324709618761754. eCollection 2018 Jan-Dec.
Drug-induced liver injury (DILI) is the most common cause of acute liver failure in the USA. DILI can be broadly classified as Intrinsic and Idiosyncratic. Identifying predictors and at-risk patients are challenging but can have a substantial clinical implication. This case report series demonstrates the importance of valproic acid, fluconazole, and amiodarone as potential hepatoxic agents of drug-induced liver injury leading to acute hepatic failure. The causality in all cases was established by Roussel Uclaf Causality Assessment Method/Council for International Organizations of Medical Sciences score and Naranjo Algorithm. Obesity, hypo-perfusion state, and concurrent hepatotoxic agent might identify at-risk patients. Further studies are required to understand the risk factors.
药物性肝损伤(DILI)是美国急性肝衰竭最常见的病因。DILI可大致分为内在性和特异质性。识别预测因素和高危患者具有挑战性,但可能具有重大的临床意义。本病例报告系列证明了丙戊酸、氟康唑和胺碘酮作为导致急性肝衰竭的药物性肝损伤潜在肝毒性药物的重要性。所有病例的因果关系均通过鲁塞尔·优克福因果关系评估方法/国际医学科学组织理事会评分和纳兰霍算法确定。肥胖、低灌注状态和同时使用肝毒性药物可能识别出高危患者。需要进一步研究以了解危险因素。